 The Star-Ledger – NJ.com |
J.&J. Will Buy a Stroke-Treatment Company for $480 Million
New York Times Johnson & Johnson said on Monday that it would buy the Micrus Endovascular Corporation, which makes medical devices, for about $480 million in cash, or $23.40 a share. Micrus Endovascular, based in San Jose, Calif., makes catheters … J&J Buying Stroke-Treatment Co Micrus For $480M Johnson & Johnson paying $480 million for Micrus Johnson & Johnson to Acquire Micrus for $480 Million |
Related posts:
- Bold Stroke May Be Beyond Europe’s Means – New York Times
- Tesla Aims for $185 Million in First Offering – New York Times
- British Regulator Fines JPMorgan $49 Million – New York Times
- Donor to Democrats Pleads Guilty to $292 Million Fraud – New York Times
- Koch Outraged By Obama’s Treatment of Israel – FOXNews
Secured by